Hansa Biopharma’s CEO Renée Aguiar-Lucander named one of Sweden’s Most Influential Business Women of 2026
Lund, Sweden, 29 May 2026. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today are proud to announce that Renée Aguiar-Lucander, CEO, Hansa Biopharma has been named one of Sweden’s Most Influential Business Women of 2026 by Dagens industri.
This nomination recognizes leaders with significant influence over the development, competitiveness and future of Swedish business. The award reflects both individual leadership and the role Hansa Biopharma plays in driving growth, innovation and competitiveness.
